Phase descriptionUsP
classification
NX-C18 ThemostruggedGeminicolumn,offering5timesthedurabilityofpreviousgenerationhybridcolumns
L1
C6-Phenyl Alowbleedphenylphase.ForUVandMSdetection,whichoffersanaromaticselectivitycomplementarytoC18phases
L11
C18 Selectivity,highstructuralintegrityandincreasedloadabilityforpreparativeandpurificationapplicationsinpre-packedcolumnsandbulkmedia
L1
Second-Generation TWIN-NX™ TechnologyTWIN-NX technology uses an improved patented organo-silica grafting process which incorporates highly stabilizing ethane cross-linking. These organic groups are evenly incorporated into the grafted layers on the silica surface while maintaining a pure silica core. This not only provides resistance to high pH attack, but also maintains the high efficiency and mechanical strength of a silica particle.
O
SiCH2
CH2
O
O
O
Si S
O
O
Si
O O
O
O
Si
O
O Si Si
O
O
Si
O
O
O
Si Si
O
Si SiOOCH2
CH2
CH2
CH2
CH2
CH2
CH2
CH2
CH2
CH2
C
C
O
SiCH2
CH2
O
O
O
Si Si
O
O
Si
O O
O
O
Si
O
O Si Si
O
O
Si
O
O
O
Si Si
O
Si SiOOCH2
CH2
CH2
CH2
CH2
CH2
CH2
CH2
CH2
CH2
CH2
CH2
C
TWIN™ (Two-In-One) Technology™
During the final stage of silica manufacturing a unique silica-organic layer is grafted to create a completely new composite particle. Since the internal base silica is unaltered by this manufacturing pro-cess, the particle retains its mechanical strength and rigidity along with excellent efficiency, while the silica-organic shell protects the particle from chemical attack.
Setting the Standard for pH Method DevelopmentRugged reversed phase HPLC columns that offer extended lifetime at extreme pH conditions and excellent stability for reproducible, high efficiency separations.
• Take full advantage of high and low pH conditions (pH 1-12) to manipulate selectivity
• Expect longer column lifetime with patented TWIN-NX™
technology
• For analytical and preparative separations of basic and acidic compounds
O
O O
O
O
O O O O O O O O
O O O O O O O
O O O O O O O
O O O O O O
O O O O O O O
O
O
O
O
O
O O O O O O
O O O O O O
O O O O O O
O O O O O O
O O O O O O
O O O O O O O
Si Si Si Si Si Si Si Si
Si Si Si Si Si Si Si Si
Si Si Si Si Si Si Si Si
Si Si Si Si Si Si Si Si
Si Si Si Si Si Si Si Si
Si Si Si Si Si Si Si Si
O O O O
O O O O O O O
O Si Si Si Si Si Si Si Si
O O O O
O
O
O O
O
O O O
O O
O Si
Si
Si
Si
Si
Si
Si Si Si Si
Si
Si
Si
Si
Si
Si
Si
Si
Si
Si Si Si
Si
Si
O
OH
OH
OH
OH
OH
OH
OH
O OH
OH
OH
OH
O
O O
O O
O
OH
OH
O
O O
Si
O Si
O OH
O
O
R
R
R
R
R
R
R R
R R R
R R
R
R R
R
R R
R
R
R
R
R R
R
R
R
HPLc|GEMINI
If Gemini analytical columns do notprovideatleastanequivalentseparationascompared toacompetingcolumnofsimilar particle size, similar phase anddimensions, send in your comparativedatawithin45daysandkeeptheGeminicolumnforFREE.
Архангельск (8182)63-90-72 Астана (7172)727-132 Астрахань (8512)99-46-04 Барнаул (3852)73-04-60 Белгород (4722)40-23-64 Брянск (4832)59-03-52 Владивосток (423)249-28-31 Волгоград (844)278-03-48 Вологда (8172)26-41-59 Воронеж (473)204-51-73 Екатеринбург (343)384-55-89
Иваново (4932)77-34-06 Ижевск (3412)26-03-58 Иркутск (395)279-98-46 Казань (843)206-01-48 Калининград (4012)72-03-81 Калуга (4842)92-23-67 Кемерово (3842)65-04-62 Киров (8332)68-02-04 Краснодар (861)203-40-90 Красноярск (391)204-63-61 Курск (4712)77-13-04 Липецк (4742)52-20-81
Магнитогорск (3519)55-03-13 Москва (495)268-04-70 Мурманск (8152)59-64-93 Набережные Челны (8552)20-53-41 Нижний Новгород (831)429-08-12 Новокузнецк (3843)20-46-81 Новосибирск (383)227-86-73 Омск (3812)21-46-40 Орел (4862)44-53-42 Оренбург (3532)37-68-04 Пенза (8412)22-31-16
Пермь (342)205-81-47 Ростов-на-Дону (863)308-18-15 Рязань (4912)46-61-64 Самара (846)206-03-16 Санкт-Петербург (812)309-46-40 Саратов (845)249-38-78 Севастополь (8692)22-31-93 Симферополь (3652)67-13-56 Смоленск (4812)29-41-54 Сочи (862)225-72-31 Ставрополь (8652)20-65-13
Сургут (3462)77-98-35 Тверь (4822)63-31-35 Томск (3822)98-41-53 Тула (4872)74-02-29 Тюмень (3452)66-21-18 Ульяновск (8422)24-23-59 Уфа (347)229-48-12 Хабаровск (4212)92-98-04 Челябинск (351)202-03-61 Череповец (8202)49-02-64 Ярославль (4852)69-52-93
Киргизия (996)312-96-26-47 Казахстан (772)734-952-31 Таджикистан (992)427-82-92-69
http://phenomenex.nt-rt.ru || [email protected]
188 Phenomenex
SFCAPPROVED
Step 1 24x High pH Flush Procedures
Mobile Phase: A:10mMAmmoniumBicarbonateph10.5B:Acetonitrile
Gradient: 5%to95%Bin6minholdat95%Bfor2min
re-equilibrate: 5%Bfor2minflow rate: 1.5mL/min
Step 2 High pH Testing
Isocratic: 10mMAmmoniumBicarbonateph10.5/Acetonitrile(50:50)
flow rate: 1.5mL/mindetection: UV@230nmsamples: 1.
2.TetracaineDiphenhydramine
Step 3 1x Neutral Flush Procedure
Mobile Phase: A:WaterB:Acetonitrile
Gradient: 5%Bfor2min5%to100%Bin3minholdat100%Bfor5min
flow rate: 1.5mL/min
Step 4 Neutral pH Testing
Isocratic: Water/Acetonitrile(35:65)flow rate: 1.0mL/mindetection: UV@254nmsamples: 1.
2.3.4.
AcetophenoneBenzeneTolueneAcenaphthene
Step 5 24x Low pH Flush Procedure
Mobile Phase: A:0.5%FormicAcidinWaterB:0.5%FormicAcidinAcetonitrile,ph2.0
Gradient: 5%to95%Bin6minholdat95%Bfor2min
re-equilibrate: 5%Bfor2minflow rate: 1.5mL/min
Step 6Neutral pH Flush Repeats
Repeats for 20 Cycles
Column Testing Cycle
0 5 10 15 20
Cycles of Exposure
% o
f Ini
tial E
f�ci
enci
es
110
100
90
80
70
60
50
Diphenhydramine
Tetracaine
0 5 10 15 20
Sequence
Ret
entio
n in
Min
utes
6
5
4
3
2
1
0
Retention Times of Four Probes Maintained in Neutral pH Testing for 20 Cycles
Column Used:column: GeminiNX-C185µm
dimensions: 150x4.6mmPart no.: 00F-4454-E0
AcetophenoneBenzene
Toluene
Acenaphthene
Gemini NX-C18 Tested for Extreme Durability in Changing Mobile Phase pHColumn Efficiencies Maintained in High pH Testing for 20 Cycles
U.S. Patent No. 7, 563, 367
Material Characteristics
Packing Material
Particle shape/size
(µm)
Pore size (Å)
surface area
(m2/g)
carbon Load
%end
capping
GeminiNX-C18 Spherical3,5,10 110 375 14 TMS
Gemini NX-C18• Control selectivity of ionizable compounds for
optimized methods
• Consistent performance in both volatile and non-volatile buffers
• High sample loading capacity for metabolite identification and preparative purification
• pH stable 1-12 for durability
pH stability: 1.0 – 12.0ParticleSize: 3µm,5µm,and10μm
Phase: C18Application: Smallmolecules,basiccompoundsStrength: Mostdurablephstableparticle
Lc/Ms certifiedUsP: L1
stable efficiencies after exposure to 10,000 column Volumes
of High and Low pH Buffers
retention times Maintained after exposure to 10,000 column Volumes
of High and Low pH Buffers
GEMINI|
H
PLc
Gemini®
189Phenomenex
SFCAPPROVED
Polar Bases at High pH, pH 10.5
Polar Bases (Antihistamines) in Formic AcidConditionsforallcolumns:
dimensions: 150x4.6mmMobile Phase: A:0.1%FormicAcidinWater
B:0.1%FormicAcidinAcetonitrileGradient: A/B(90:10)to(50:50)in10min
flow rate: 1.5mL/mintemperature: Ambient
detection: UV@210nm
sample: 1.2.3.4.5.6.7.
PyrilamineTripelennamineChlorpheniramineBrompheniramineChloropyramineDiphenhydramineLoratadine
Y-axis normalized for all chromatograms.
0 2 4 6
1,2 3 45
6
7
8 10 12 min
AppID16633
Waters XBridge 5 µm C18
Polar Bases (Beta Blockers) at High pHConditionsforallcolumns:
dimensions: 150x4.6mmMobile Phase: A:10mMAmmoniumBicarbonateph10.5
B:AcetonitrileGradient: A/B(85:15)to(70:30)in15minto(50:50)in
5min,holdfor5minflow rate: 1.5mL/min
temperature: Ambientdetection: UV@230nm
sample: 1. BisoprololContaminant 2. Sotalol 3. Atenolol 4. Labetalol(DiastereoisomericPair) 5. Nadolol(DiastereoisomericPair) 6. Pindolol 7. Metoprolol 8. Bisoprolol 9. Propranolol10. Alprenolol
Y-axis normalized for all chromatograms.
Polar Bases at Low pH, pH 2.7
0 10 20 min
1
2
3
4 6
7
8
9
10
}
5
}
0 2 4
12 3
45
67
6 8 10 12 min
Gemini NX-C18 5 µm
AppID16606
AppID16641
U.S. Patent No. 7, 563, 367
Comparative chromatograms may not be representative of all applications.
XBridge and Waters are registered trademarks of Waters Corporation. Phenomenex is in no way affiliated with Waters Corporation.
Waters® XBridge® 5 µm C18Gemini NX-C18 5 µm
0 10 20 min
1
2
3
4,56
78
9
10
AppID16642
HPLc|GEMINI
Gemini®
190 Phenomenex
SFCAPPROVED
Low
pH
Hig
h p
H
• Increased loading and retention of basic compounds
• Wide pH stability from 1-12
• Silica efficiency and mechanical strength
• Excellent media for process-scale purification
Material Characteristics
Packing Material
Particle shape/size
(µm)
Pore size (Å)
surface area
(m2/g)
carbon Load
%end
capping
GeminiC18 Spherical3,5,10 110 375 14 TMS
Conditionsforallseparations:column: Gemini5μmC18
dimension: 150x4.6mmPart no.: 00F-4435-E0
Mobile Phase: 10mMAmmoniumBicarbonate,ph10.5/Acetonitrile(50:50)
flow rate: 1.0mL/mintemperature: Ambient
detection: UV@230nmsample: 1.Pindolol
2.Metoprolol3.Propranolol
0 2 4 6 8 min
1
2
3
Batch 1
Batch 2
Batch 3
Batch 4
Batch-to-Batch Reproducibility pH Quick Guide
AppID15818
Gemini C18U.S. Patent No. 7, 563, 367
Effects of Mobile Phase pH on Bases
Low
pH
Hig
h p
H
Below pKa
At pKa
Above pKa
Effects of Mobile Phase pH on Acids
Below pKa
At pKa
Above pKa
Bases
Acids
pH stability: 1.0 – 12.0ParticleSize: 3µm,5µm,and10μm
Phase: C18Application: Smallmolecules,basiccompoundsStrength: Widephstability,highefficiency
Lc/Ms certifiedUsP: L1Gemini C18
GEMINI|
H
PLc
Gemini®
191Phenomenex
SFCAPPROVED
Virtually No LC/MS BleedThe increased stability of Gemini columns provide the ultra-low bleed profile required for high sensitivity LC/MS applications. The advanced TWIN™ Technology used for Gemini columns limit phase cleavage and stabilizes the silica surface. When compared against a background MS profile, Gemini columns demonstrate virtually no column bleed across a wide mass range.
Extended Column LifetimeThe TWIN™ Technology engineering of Gemini provide stability and increased column lifetime. Whether used under isocratic or gradi-ent conditions, Gemini columns out-perform and outlasts pH stable columns. This is illustrated below.
Lifetime and Efficiency Comparison**
0
2000
4000
6000
8000
10000
12000
14000
16000
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 Days
† Columns fail after 50 % loss in efficiency.
5.5 times increased column lifetime and still going!
Gemini Fail Line
XTerra® Fail Line
†Efficiency and lifetime comparison based on average of two columns each run in parallel.
Effi
cien
cy (N
)
Gemini C18 Waters® XTerra® MS C18
121 2 3 4 5 6 7 8 9 10 11 min0.0
1.0e7
2.0e7
3.0e7
4.0e7
5.0e7
6.0e7
7.0e7
8.0e7
9.0e7
Essentially no bleed!
Total Ion Current
Gemini C18 Background MS Profile
**Thecomparativedatapresentedheremaynotberepresentativeforallapplications.GeminiisaregisteredtrademarkofPhenomenex.
TWINandTwo-In-OneTechnologyaretrademarksofPhenomenex.WatersandXTerraareregisteredtrademarksofWatersCorp.
ZORBAXisaregisteredtrademarkofAgilentTechnologies.ACEisaregisteredtrademarkofAdvancedChromatographyTechnologiesLimited.
PhenomenexisnotassociatedinanywaywithWatersCorp,AgilentTechnologiesorACT.
2 0 4 6 8 10 12 14 min
1
2
3 4
15595
min 0 2 4 6 8 10 12 14
1
2 3 4
15596
2 0 4 6 8 10 12 14 min
1 2
3 4
15602
Chromatographic Comparisons**
Conditionsforallcolumns:columns: Gemini5μmC18
Waters®XTerra®5μmMSC18dimensions: 150x4.6mm
Mobile Phase: Acetonitrile/50mMMethylpyrrolidineBuffer,ph11.5(50:50)
flow rate: 1mL/mintemperature: Ambient
detection: UV@254nmsample: Diphenhydramine
Conditionsforallcolumns:column: Gemini5μmC18
dimension: 150x3.0mmPart no.: 00F-4435-Y0
Mobile Phase: A:0.1%hCOOhinAcetonitrileB:0.1%hCOOhinWater
Gradient: 5:95(A/B)linearto95:5over8min,holdfor5min
flow rate: 0.5mL/mindetection: API3000
IonSource:ESI/PIMScanRate:13000m/z/sScanRange:60-1000
Tricyclic Antidepressants at Neutral pHConditionsforallcolumns:
dimensions: 150x4.6mmMobile Phase: 20mMPhosphatebufferph7.0/Acetonitrile/
Methanol(30:35:35)flow rate: 1.5mL/mindetection: UV@254nm
sample: 1.Nortriptyline2.Imipramine3.Amitriptyline4.Clomipramine
AppID15602
AppID15596
AppID15595
Gemini 5 µm C18 110 Å Agilent Technologies® ZoRBAX® 5 µm Extend-C18 80 Å
Advanced Chromotography Technologies ACE® 5 µm C18 100 Å
U.S. Patent No. 7, 563, 367
Virtually no silanol interactions!
HPLc|GEMINI
Gemini®
192 Phenomenex
SFCAPPROVED
min0 5 10 15
min0 5 10 15
1 2
3
1 2
3
mAU
0
mAU
0
80
40
120
60
40
20
Gemini C6-Phenyl
N
N
N H
H2N
CH3
O O
S
O O
S S
N N H
H2N
resolution Pursuit® 5 µm diPhenyl Gemini 5 µm c6-Phenyl
Rs1,2 1.0 4.0Rs2,3 9.8 16.0
Conditionsforallcolumns:dimensions: 150x3.0mm
Mobile Phase: A:0.1%FormicacidinWaterB:0.1%FormicacidinAcetonitrile
Gradient: 5%Bto95%Bin10min,thenhold95%Bfor2min
flow rate: 0.6mL/mintemperature: Ambient
Ms detection: ESI+ionmode,M/Z100-700
Low Bleed Phenyl PhaseOne of the weaknesses of traditional phenyl phases has been excessive bleed in UV and MS. Gemini C6-Phenyl columns demonstrate far lower bleed than many other phenyl columns. Indeed, in this example the Gemini C6-Phenyl column shows lower bleed than a popular C18 column.
2 0 4 6 8 10 12 min 0.0
1.0e7
2.0e7
3.0e7
4.0e7
5.0e7
6.0e7
7.0e7
8.0e7
9.0e7
Intensity cps
Popular C18
Gemini C6-Phenyl
Blank
Enhanced Performance for Aromatic Compounds Sulfa Drug Application
Conditionsforallcolumns:dimensions: 150x4.6mm
Mobile Phase: 0.1%FormicAcidinWater/Methanol(70:30)
flow rate: 1.0mL/mintemperature: Ambient
detection: UV@254nmsample: 1.Sulfathiazole
2.Sulfamerazine3.Sulfamethoxazole
• Good selectivity for aromatic compounds
• Extremely low UV and MS bleed
• Wide pH stability from 1-12
The comparative data presented here may not be representative for all applications. Agilent and Pursuit are registered trademarks of Agilent Technologies, Inc.
Reproducible Phenyl Phase Aliphatic Acid Application
min 0 1 2 3 4 5 6 7 8 9
Phenomenex Gemini 5 μm C6-Phenyl
Agilent Technologies® Pursuit® 5 μm DiPhenyl
AppID15903
AppID15908
U.S. Patent No. 7, 563, 367
Conditionsforallcolumns:column: Gemini5µmC6-Phenyl
dimensions: 150x4.6mmPart no.: 00F-4444-E0
Mobile Phase: 20mMPhosphatebuffer,ph2.5/Methanol(97:3)
flow rate: 1.0mL/mintemperature: Ambient
detection: UV@220nmsample: 1.TartaricAcid4.AceticAcid
2.MalicAcid5.CitricAcid3.LacticAcid6.PropionicAcid
Material Characteristics
Packing Material
Particle shape/size
(µm)
Pore size (Å)
surface area
(m2/g)
carbon Load
%end
capping
GeminiC6-Phenyl Spherical3,5 110 375 12 TMS
pH stability: 1.0 – 12.0ParticleSize: 3µmand5µm
Phase: PhenylwithC6linkerApplication: Aromatic,polar,orbasiccompoundsStrength: higharomaticselectivitywithexceptionalpeak
shapeeveninneutralconditions.Extremelylowbleedphenylcolumn.
Lc/Ms certifiedUsP: L11Gemini C6-Phenyl
Sulfathiazole
Sulfamerazine
GEMINI|
H
PLc
Gemini®
193Phenomenex
SFCAPPROVED
0 2 4 6 8
52
54
56
58
60
62
64
66
68
mAU
21874
min
1
2
AppID21874
ApplicationsU.S. Patent No. 7, 563, 367
Mycotoxin Screening
column: Gemini5μmC18dimensions: 150x4.6mm
Part no.: 00F-4435-E0Mobile Phase: A:Water/Methanol(90:10)containing5mMAmmoniumacetate
and1%AceticacidB:Water/Methanol(3:97)containing5mMAmmoniumacetateand1%Aceticacid
Gradient: time (min) % B0 014 10018.01 020.5 0
flow rate: 1mL/mintemperature: 25°C
detection: TandemMassSpectrometer(MS/MS)(25°C)detector: ABSCIEXAPI4000™Systemsample: 1.Lincomycin
2.Ergometrine3.AflatoxinG24.AflatoxinG15.AflatoxinB26.Ergocryptine7.AflatoxinB1
8.Ergocryptinine9.OchratoxinA10.Nigirin11.Chloramphenicol12.b-Zearalenol13.Rapamycin
TMP and Thiamine
column: Gemini3μmNX-C18dimensions: 100x3.0mm
Part no.: 00D-4453-Y0Mobile Phase: A:25mMNa2HPO4with10%methanol(ph7.0)
B:25mMNa2HPO4with70%methanol(ph7.0)Gradient: time (min) % B time (min) % B
0 97 4 00.25 75 5 00.75 75 5.1 973 65 8 97
flow rate: 0.75mL/mindetection: Fluorescence(Excitation:375nm,Emission:435nm)(Ambient)
temperature: 22°Csample: 1.TMP
2.Thiamine
0.50 1 1.5 2 2.5 3 3.5 min0
2.0e4
4.0e4
6e4
8e4
1e5
1.2e5
1.4e5
1.6e5
1.8e5
2e5
2.2e5
2.4e5
2.6e5
2.8e5
1
2
3e5
3.2e5
3.4e5
3.6e5
20909
Inte
nsity
, cp
s
AppID20909
Vitamin B3
column: Gemini3μmC18dimensions: 100x4.6mm
Part no.: 00D-4439-E0Mobile Phase: A:0.1%FormicacidinWater
B:MethanolGradient: time (min) % B
0 102.5 902.6 104 10
flow rate: 0.6mL/mintemperature: 22°C
detection: ElectrosprayMassSpec(ESMS)(22°C)detector: ABSCIEXAPI4000™Systemsample: 1.Nicotinamide
2.Nicotinicacid
Hormones in Drinking Water: EPA Method 539
column: Gemini3μmNX-C18dimensions: 100x2.0mm
Part no.: 00D-4453-B0Mobile Phase: A:0.2%Nh4OhinWater
B:0.2%Nh4OhinMethanolGradient: time (min) % B time (min) % B
0.00.10.607.50
35356565
8.5013.013.0115.0
85853535
flow rate: 0.2mL/mintemperature: 22˚C
detection: TandemMassSepectrometer(MS/MS)(22˚C)detector: ABSCIEXAPI4000™Systemsample: 1.Estriol 8.Ethynylestradiol-d4
2.Estriol-d2(IS) 9.17a-Ethynylestradiol3.BisphenolA-d16 10.13C2-Ethynylestradiol(IS)4.Equilin 11.Androstenedione5.Estrone 12.Testosterone-d36.Beta-estradiol 13.Testosterone7.13C6-estradiol(IS)
1.0
1,2
6-11
12,13
3
4
5
0 .02.0 3.0 4.0 5.0 6.0 7.0 8.0 9.0 10.0 11.0 12.0 13.0 14.0 min
21 41 62 82 102 123 143 163 184 204 224 244 265 285
2.0e4
4.0e4
6.0e4
8.0e4
1.0e5
1.2e5
1.4e5
1.6e5
1.8e5
2.0e5
2.2e5
2.4e5
2.6e5
2.8e5
3.0e5
3.2e5
3.4e5
3.6e5
3.8e5
4.0e5
Inte
nsity
, cps
AppID21939
05.0e41.0e51.5e52.0e52.5e53.0e53.5e54.0e54.5e55.0e55.5e5
20027
Inte
nsity
, cp
sIn
tens
ity, c
ps
20 4 6 8 10 12 14 16 18 min 200
20 4 6 8 10 12 14 16 18 min 20
1.0e4
2.0e4
3.0e4
4.0e4
5.0e4
6.0e4
1
2
3
45
6
7
8
910
11
12
13AppID20027
Positive Polarity
negative Polarity
243* Mycotoxins and Metabolites in 20 Minutes!
05.0e41.0e51.5e52.0e52.5e53.0e53.5e54.0e54.5e55.0e55.5e5
20027
Inte
nsity
, cp
sIn
tens
ity, c
ps
20 4 6 8 10 12 14 16 18 min 200
20 4 6 8 10 12 14 16 18 min 20
1.0e4
2.0e4
3.0e4
4.0e4
5.0e4
6.0e4
1
2
3
45
6
7
8
910
11
12
13
HPLc|GEMINI
Gemini®
194 Phenomenex
SFCAPPROVED
3 μm analytical columns (mm) securityGuard™ cartridges (mm)Phases 20 x 4.0 30 x 4.6 50 x 4.6 100 x 4.6 150 x 4.6 250 x 4.6 4 x 3.0*
/10pkC18 00M-4439-D0 00A-4439-E0 00B-4439-E0 00D-4439-E0 00F-4439-E0 00G-4439-E0 AJ0-7597C6-Phenyl — 00A-4443-E0 00B-4443-E0 00D-4443-E0 00F-4443-E0 00G-4443-E0 AJ0-7915
— — /10pkNX-C18 — — 00B-4453-E0 00D-4453-E0 00F-4453-E0 00G-4453-E0 AJ0-8368
forID:3.2-8.0mm
5 μm analytical columns (mm) securityGuard™ cartridges (mm)Phases 30 x 4.6 50 x 4.6 100 x 4.6 150 x 4.6 250 x 4.6 4 x 3.0*
/10pkC18 00A-4435-E0 00B-4435-E0 00D-4435-E0 00F-4435-E0 00G-4435-E0 AJ0-7597C6-Phenyl 00A-4444-E0 00B-4444-E0 00D-4444-E0 00F-4444-E0 00G-4444-E0 AJ0-7915
— /10pkNX-C18 — 00B-4454-E0 00D-4454-E0 00F-4454-E0 00G-4454-E0 AJ0-8368
forID:3.2-8.0mm
Ordering Information
3 μm Microbore, Minibore and narrow Bore columns (mm) securityGuard™ cartridges (mm)Phases 50 x 1.0 20 x 2.0 30 x 2.0 50 x 2.0 100 x 2.0 150 x 2.0 50 x 3.0 100 x 3.0 150 x 3.0 4 x 2.0*
/10pkC18 00B-4439-A0 00M-4439-B0 00A-4439-B0 00B-4439-B0 00D-4439-B0 00F-4439-B0 00B-4439-Y0 00D-4439-Y0 00F-4439-Y0 AJ0-7596
C6-Phenyl 00B-4443-A0 — 00A-4443-B0 00B-4443-B0 00D-4443-B0 00F-4443-B0 00B-4443-Y0 00D-4443-Y0 00F-4443-Y0 AJ0-7914— /10pk
NX-C18 — 00M-4453-B0 00A-4453-B0 00B-4453-B0 00D-4453-B0 00F-4453-B0 00B-4453-Y0 00D-4453-Y0 00F-4453-Y0 AJ0-8367forID:2.0-3.0mm
For PREP Columns & Bulk Media, see p. 345For SecurityGuard Holders and Cartridges, see p. 254For MercuryMS LC/MS Columns, Cartridges, and Cartridge Holders, Inquire.
For Gemini Capillary HPLC Columns, Guards, and Adapter, contact your Phenomenex technical consultant or local distributor.
*SecurityGuard™AnalyticalCartridgesrequireholder,PartNo.:KJ0-4282‡SemiPrepSecurityGuard™Cartridgesrequireholder,PartNo.:AJ0-7220
**PREPSecurityGuard™Cartridgesrequireholder,PartNo.:AJ0-8223PREPSecurityGuard™Cartridgesrequireholder,PartNo.:AJ0-8277
5 μm semi-Prep columns (mm) securityGuard™ cartridges (mm)Phases 150 x 10 250 x 10 10 x 10‡
/3pkC18 00F-4435-N0 00G-4435-N0 AJ0-7598C6-Phenyl — 00G-4444-N0 AJ0-9156
/3pkNX-C18 00F-4454-N0 00G-4454-N0 AJ0-8369
forID:9-16mm
U.S. Patent No. 7, 563, 367
axia™ Packed Preparative columns (mm) securityGuard™ cartridges (mm)Phases 50 x 21.2 100 x 21.2 150 x 21.2 250 x 21.2 50 x 30 75 x 30 15 x 21.2** 15 x 30.05 μm /ea /eaC18 00B-4435-P0-AX 00D-4435-P0-AX 00F-4435-P0-AX 00G-4435-P0-AX 00B-4435-U0-AX 00C-4435-U0-AX AJ0-7846 AJ0-8308C6-Phenyl — 00D-4444-P0-AX 00F-4444-P0-AX 00G-4444-P0-AX — 00C-4444-U0-AX AJ0-9157 AJ0-91585 μm /ea /eaNX-C18 00B-4454-P0-AX 00D-4454-P0-AX 00F-4454-P0-AX 00G-4454-P0-AX 00B-4454-U0-AX 00C-4454-U0-AX AJ0-8370 AJ0-837110 μm — /ea /eaC18 00B-4436-P0-AX 00D-4436-P0-AX 00F-4436-P0-AX 00G-4436-P0-AX 00B-4436-U0-AX — AJ0-7846 AJ0-830810 μm — /ea /ea
NX-C18 00B-4455-P0-AX 00D-4455-P0-AX 00F-4455-P0-AX 00G-4455-P0-AX — — AJ0-8370 AJ0-8371forID:18-29mm 30-49mm
5 μm Minibore and narrow Bore columns (mm) securityGuard™ cartridges (mm)Phases 30 x 2.0 50 x 2.0 150 x 2.0 250 x 2.0 50 x 3.0 100 x 3.0 150 x 3.0 250 x 3.0 4 x 2.0*
/10pkC18 00A-4435-B0 00B-4435-B0 00F-4435-B0 00G-4435-B0 00B-4435-Y0 00D-4435-Y0 00F-4435-Y0 00G-4435-Y0 AJ0-7596C6-Phenyl 00A-4444-B0 00B-4444-B0 00F-4444-B0 — 00B-4444-Y0 — 00F-4444-Y0 00G-4444-Y0 AJ0-7914
— /10pkNX-C18 00A-4454-B0 00B-4454-B0 00F-4454-B0 — 00B-4454-Y0 00D-4454-Y0 00F-4454-Y0 00G-4454-Y0 AJ0-8367
forID:2.0-3.0mm
axia™ Packed Preparative columns (mm) continued securityGuard™ cartridges (mm)Phases 100 x 30 150 x 30 250 x 30 50 x 50 100 x 50 150 x 50 250 x 50 15 x 30.0♦ 5 μm Inquire Inquire Inquire — — — /eaC18 00D-4435-U0-AX 00F-4435-U0-AX 00G-4435-U0-AX 00B-4435-V0-AX — — — AJ0-8308C6-Phenyl 00D-4444-U0-AX — — — — — — AJ0-91585 μm Inquire Inquire Inquire — — — — /ea
NX-C18 00D-4454-U0-AX 00F-4454-U0-AX 00G-4454-U0-AX — — — — AJ0-837110 μm Inquire Inquire Inquire Inquire Inquire Inquire /eaC18 00D-4436-U0-AX 00F-4436-U0-AX 00G-4436-U0-AX 00B-4436-V0-AX 00D-4436-V0-AX 00F-4436-V0-AX 00G-4436-V0-AX AJ0-830810 μm Inquire Inquire Inquire Inquire Inquire Inquire /eaNX-C18 00D-4455-U0-AX 00F-4455-U0-AX 00G-4455-U0-AX 00B-4455-V0-AX 00D-4455-V0-AX 00F-4455-V0-AX 00G-4455-V0-AX AJ0-8371
forID:30-49mm
GEMINI|
H
PLc
Gemini®
If Gemini analytical columns do not provide at least anequivalent separation as compared to a competing columnof similar particle size, similar phase and dimensions, sendinyourcomparativedatawithin45daysandkeeptheGeminicolumnforFREE.
axia™ Packed Preparative columns (mm) continued securityGuard™ cartridges (mm)Phases 100 x 30 150 x 30 250 x 30 50 x 50 100 x 50 150 x 50 250 x 50 15 x 30.0♦ 5 μm — — — /ea
C18 00D-4435-U0-AX 00F-4435-U0-AX 00G-4435-U0-AX 00B-4435-V0-AX — — — AJ0-8308C6-Phenyl 00D-4444-U0-AX — — — — — — AJ0-91585 μm — — — — /ea
NX-C18 00D-4454-U0-AX 00F-4454-U0-AX 00G-4454-U0-AX — — — — AJ0-837110 μm /eaC18 00D-4436-U0-AX 00F-4436-U0-AX 00G-4436-U0-AX 00B-4436-V0-AX 00D-4436-V0-AX 00F-4436-V0-AX 00G-4436-V0-AX AJ0-830810 μm /eaNX-C18 00D-4455-U0-AX 00F-4455-U0-AX 00G-4455-U0-AX 00B-4455-V0-AX 00D-4455-V0-AX 00F-4455-V0-AX 00G-4455-V0-AX AJ0-8371
forID:30-49mm
Архангельск (8182)63-90-72 Астана (7172)727-132 Астрахань (8512)99-46-04 Барнаул (3852)73-04-60 Белгород (4722)40-23-64 Брянск (4832)59-03-52 Владивосток (423)249-28-31 Волгоград (844)278-03-48 Вологда (8172)26-41-59 Воронеж (473)204-51-73 Екатеринбург (343)384-55-89
Иваново (4932)77-34-06 Ижевск (3412)26-03-58 Иркутск (395)279-98-46 Казань (843)206-01-48 Калининград (4012)72-03-81 Калуга (4842)92-23-67 Кемерово (3842)65-04-62 Киров (8332)68-02-04 Краснодар (861)203-40-90 Красноярск (391)204-63-61 Курск (4712)77-13-04 Липецк (4742)52-20-81
Магнитогорск (3519)55-03-13 Москва (495)268-04-70 Мурманск (8152)59-64-93 Набережные Челны (8552)20-53-41 Нижний Новгород (831)429-08-12 Новокузнецк (3843)20-46-81 Новосибирск (383)227-86-73 Омск (3812)21-46-40 Орел (4862)44-53-42 Оренбург (3532)37-68-04 Пенза (8412)22-31-16
Пермь (342)205-81-47 Ростов-на-Дону (863)308-18-15 Рязань (4912)46-61-64 Самара (846)206-03-16 Санкт-Петербург (812)309-46-40 Саратов (845)249-38-78 Севастополь (8692)22-31-93 Симферополь (3652)67-13-56 Смоленск (4812)29-41-54 Сочи (862)225-72-31 Ставрополь (8652)20-65-13
Сургут (3462)77-98-35 Тверь (4822)63-31-35 Томск (3822)98-41-53 Тула (4872)74-02-29 Тюмень (3452)66-21-18 Ульяновск (8422)24-23-59 Уфа (347)229-48-12 Хабаровск (4212)92-98-04 Челябинск (351)202-03-61 Череповец (8202)49-02-64 Ярославль (4852)69-52-93
Киргизия (996)312-96-26-47 Казахстан (772)734-952-31 Таджикистан (992)427-82-92-69
http://phenomenex.nt-rt.ru || [email protected]